Capitalization 209B 17,455B P/E ratio 2024 *
34.1x
P/E ratio 2025 * 29.4x
Enterprise value 232B 19,409B EV / Sales 2024 *
5.4x
EV / Sales 2025 * 4.96x
Free-Float
86.05%
Yield 2024 *
0.27%
Yield 2025 * 0.3%
More valuation ratios * Estimated data
Dynamic Chart
1 day+2.26%
1 week+0.32%
Current month-1.19%
1 month-3.22%
3 months-0.36%
6 months-1.26%
Current year+2.94%
More quotes
1 week
531.48
Extreme 531.475
559.96
1 month
528.37
Extreme 528.37
571.51
Current year
527.32
Extreme 527.32
603.82
1 year
415.60
Extreme 415.6
603.82
3 years
415.60
Extreme 415.6
672.34
5 years
250.21
Extreme 250.21
672.34
10 years
107.33
Extreme 107.33
672.34
More quotes
Manager TitleAgeSince
Chief Executive Officer 56 01/01/01
Director of Finance/CFO 57 01/01/01
General Counsel 62 01/18/01
Director TitleAgeSince
Director/Board Member 66 09/06/09
Chief Executive Officer 56 01/01/01
Director/Board Member 63 26/09/26
More insiders

Other Advanced Medical Equipment & Technology

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+2.26%+0.32%-2.81%+4.18% 209B
+3.02%+1.89%-1.95%-13.17% 186B
+1.34%+5.46%+36.97%+42.04% 164B
+0.92%+0.32%+47.23%+79.72% 115B
+0.39%-0.82%+4.41%-2.37% 64.78B
+1.72%-1.69%-4.95%-17.81% 53.02B
-0.39%+2.40%-5.25%-37.13% 47.25B
+1.24%+1.84%+4.54%-11.23% 38.93B
+0.98%+1.30%-1.69% - 37.08B
+2.03%+0.96%-5.76%-19.53% 30.45B
Average +1.35%+1.26%+7.08%+2.74% 94.48B
Weighted average by Cap. +1.70%+1.56%+10.86%+11.68%
See all sector performances
Ratios2024 *2025 *
Net sales 43B 3,598B 45.95B 3,845B
Net income 6.18B 517B 6.94B 581B
Net Debt 23.43B 1,961B 19.3B 1,615B
More financial data * Estimated data
Logo Thermo Fisher Scientific
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Employees
1,22,000
Calendar
Related indices
More about the company
Date Price Change Volume
22/24/22 546.42 $ +2.26% 1,163,691
19/24/19 534.35 $ -1.16% 1,667,269
18/24/18 540.62 $ -2.60% 1,744,967
17/24/17 555.06 $ -0.06% 1,131,158
16/24/16 555.42 $ +1.97% 1,122,114

Delayed Quote Nyse, July 23, 2024 at 01:30 am IST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
546.42USD
Average target price
628.20USD
Spread / Average Target
+14.97%
Consensus